substance p has been researched along with Prostatic Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aghaee-Bakhtiari, SH; Ebrahimi, S; Hashemy, SI; Mirzavi, F | 1 |
| Almendro, V; Ametller, E; Casas, I; Fernández-Nogueira, P; García-Recio, S; Gascón, P; Mayordomo, C; Pastor-Arroyo, EM; Vinyals, L | 1 |
| Coleman, I; Corey, E; Dumpit, R; Higano, CS; Lakely, B; Lange, PH; Larson, SR; Montgomery, B; Morrissey, C; Nelson, PS; Roudier, M; True, LD; Vessella, RL; Zhang, X | 1 |
| Büchler, MW; Friess, H; Korc, M; Liard, V; Lieb, K; Palma, C; Reubi, JC; Shi, X; Shrikhande, SV; Wang, L; Zhu, Z; Zimmermann, A | 1 |
| Albrecht, M; Aumüller, G; Doroszewicz, J; Gillen, S; Gomes, I; Stief, T; Wilhelm, B | 1 |
| Drell, TL; Entschladen, F; Kaltschmidt, C; Lang, K; Lindecke, A; Niggemann, B; Zaenker, KS | 1 |
| Chen, B; Hasan, T; Hoopes, PJ; Pogue, BW; Zhou, X | 1 |
| Tainio, H | 1 |
| Cariou, G; Cortesse, A; Cussenot, O; Desgrandchamps, F; Fiet, J; Le Duc, A; Meria, P; Teillac, P; Valeri, A; Villette, JM | 1 |
| Fujii, H; Fuse, H; Murakami, K; Murata, J; Nagakawa, O; Ogasawara, M; Saiki, I | 1 |
10 other study(ies) available for substance p and Prostatic Neoplasms
| Article | Year |
|---|---|
SP/NK1R system regulates carcinogenesis in prostate cancer: Shedding light on the antitumoral function of aprepitant.
Topics: Animals; Antineoplastic Agents; Aprepitant; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; G2 Phase Cell Cycle Checkpoints; Humans; Male; Matrix Metalloproteinases; Mice; Mice, Nude; Prostatic Neoplasms; Protein Isoforms; Proto-Oncogene Proteins c-bcl-2; Receptors, Neurokinin-1; Substance P; Survival Rate; Transplantation, Heterologous | 2022 |
Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2.
Topics: Antibodies; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Resistance, Neoplasm; ErbB Receptors; Female; Humans; Lapatinib; Ligands; Male; Neoplasms; Neurokinin-1 Receptor Antagonists; Piperidines; Prostatic Neoplasms; Quinazolines; Receptor, ErbB-2; Receptors, Neurokinin-1; Signal Transduction; Substance P; Trastuzumab | 2012 |
Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases.
Topics: Aged; Bone Morphogenetic Proteins; Bone Neoplasms; Bone Remodeling; Endothelin-1; Gene Expression; Humans; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Male; Neoplasm Proteins; Osteoblasts; Osteolysis; Phosphoglycerate Kinase; Prostatic Neoplasms; Substance P | 2013 |
Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer.
Topics: Blotting, Western; Cell Division; Humans; Immunohistochemistry; In Situ Hybridization; Male; Prostatic Neoplasms; Receptors, Neurokinin-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substance P; Tumor Cells, Cultured | 2003 |
Proliferation of prostate cancer cells and activity of neutral endopeptidase is regulated by bombesin and IL-1beta with IL-1beta acting as a modulator of cellular differentiation.
Topics: Bombesin; Calcitonin; Calcitonin Gene-Related Peptide; Cell Differentiation; Cell Line, Tumor; Culture Media, Conditioned; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Interleukin-1; Male; Microscopy, Electron; Neprilysin; Prostatic Neoplasms; Protein Precursors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stromal Cells; Substance P | 2004 |
Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs.
Topics: Breast Neoplasms; Carcinoma; Cell Movement; Collagen; Cyclic AMP Response Element-Binding Protein; Dopamine; Dopamine Antagonists; Female; Gene Expression Regulation, Neoplastic; Humans; Image Processing, Computer-Assisted; Male; Microscopy, Video; Neoplasm Metastasis; Norepinephrine; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Signal Transduction; Substance P; Up-Regulation | 2004 |
Peptide-induced inflammatory increase in vascular permeability improves photosensitizer delivery and intersubject photodynamic treatment efficacy.
Topics: Animals; Capillary Permeability; Drug Delivery Systems; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prostatic Neoplasms; Rats; Substance P; Treatment Outcome; Vasculitis; Verteporfin | 2007 |
Peptidergic innervation of the human testis and epididymis.
Topics: Aged; Calcitonin Gene-Related Peptide; Connective Tissue; Enkephalin, Methionine; Epididymis; Galanin; Humans; Immunohistochemistry; Male; Middle Aged; Nerve Fibers; Neuropeptide Y; Neuropeptides; Peptide PHI; Peptides; Prostatic Neoplasms; Seminiferous Tubules; Substance P; Testis; Tissue Fixation; Tyrosine 3-Monooxygenase; Vasoactive Intestinal Peptide | 1994 |
Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Biomarkers, Tumor; Bombesin; Calcitonin; Chromogranin A; Chromogranins; Humans; Immunoassay; Male; Middle Aged; Neuropeptides; Neurotensin; Phosphopyruvate Hydratase; Prognosis; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Somatostatin; Substance P; Survival Rate | 1996 |
Effect of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cells.
Topics: Calcitonin Gene-Related Peptide; Cell Movement; Gastrin-Releasing Peptide; Gelatin; Humans; Male; Neoplasm Invasiveness; Neuropeptides; Prostatic Neoplasms; Substance P; Tumor Cells, Cultured | 1998 |